According to FutureWise analysis the market for Glucagon in 2023 is US$ 6.28 billion, and is expected to reach US$ 10.26 billion by 2031 at a CAGR of 6.32%.
Glucagon is an antidote to beta-blocker and calcium channel blocker overdose, anaphylaxis refractory to epinephrine, and an assistance in delivering food boluses. It belongs to the anti-hypoglycemic drug class. This exercise explains how to use glucagon to treat acute hypoglycemia, beta-blocker and calcium channel blocker overdose, refractory anaphylaxis, and esophageal blockage caused by a food bolus. This activity will also highlight the mechanism of action, adverse event profile, and other important factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions) for healthcare team members to consider when managing patients with the indicated conditions. The FDA has approved glucagon as a diagnostic tool in GI tract imaging. The role of glucagon in gastrointestinal imaging is to cause hypotonia in the colon and upper gastrointestinal system, allowing for more accurate visualisation for investigations and procedures; this is the same mechanism that allows esophageal food boluses to pass. The main indication for this drug is to reduce peristalsis during abdominal vascular procedures including treating esophageal varices and other GI bleeding. The rise in the frequency of hypoglycemia-related deaths and the prevalence of hypoglycemia in diabetic patients are both factors contributing to the market's growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Glucagon Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Glucagon Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.